产品名称 | NebuSelect™ Recombinant Human BTN3A2, Avi-His-tag |
---|---|
目录号 | NBL-243015 |
别名 | BTN3A2; BT3.2; BTF3; BTF4; BT3.3; BTN3A2; FLJ40011; BTN3.2; CD277 |
外观 | see COA |
分子量 | Gln30-Trp248 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P78410-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-243015-100ug | 100ug | Inquire | Inquire | |
NBL-243015-1mg | 1mg | Inquire | Inquire | |
NBL-243015-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human BTN3A2, Avi-His-tag
Catalog#:
NBL-243015
Description:
NebuSelect™ Recombinant Human BTN3A2, Avi-His-tag(Cat#NBL-243015) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Gln30-Trp248.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 26.5 kDa. Due to glycosylation, the protein migrates to 27-33 kDa based on Bis-Tris PAGE result.
Target Name:
BTN3A2; BT3.2; BTF3; BTF4; BT3.3; BTN3A2; FLJ40011; BTN3.2; CD277
Target Information:
BTN3A2/BT3.2 butyrophilin mRNA expression by tumoral cells was previously identified as a prognostic factor in a small cohort of high grade serous epithelial ovarian cancer (HG-EOC).In conclusion, BT3.2 protein is a potential prognostic biomarker for the identification of HG-EOC patients with better outcome. In contrast, high CD206 /CD68 expression is associated with high risk of disease progression.
Amino Acid Sequence:
Gln30-Trp248
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.